Thomas D. R.
- Country
- Belgium
- Department
- SGS - Clinical Research
Research Overview
Data & Insights
Has run more than one trial at 2 of 10 partner sites.
Specializations
Viral Hepatitis and Liver Disease
Thomas De Ridder is involved in clinical research focused on chronic hepatitis B and chronic hepatitis D virus infection, with additional interest in advanced liver disease settings such as liver cirrhosis and metabolic dysfunction-associated steatohepatitis.
- Hepatitis B
- Chronic HDV infection
- Liver cirrhosis
- Metabolic steatohepatitis
His trial portfolio includes therapeutic evaluation in virally suppressed patients and healthy volunteer settings linked to infectious liver disorders.
Respiratory and Airway Disorders
His research activity covers a broad spectrum of respiratory medicine, including asthma, chronic cough, chronic obstructive pulmonary disease, bronchiectasis, and pulmonary fibrosis.
- Asthma
- Chronic obstructive pulmonary disease
- Non-cystic fibrosis bronchiectasis
- Pulmonary fibrosis
He is also engaged in studies addressing influenza and other viral respiratory infections, reflecting a strong therapeutic focus on airway and infection-related disease management.
Immune-Mediated and Inflammatory Diseases
Thomas De Ridder participates in research across immune-mediated and inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, atopic dermatitis, hidradenitis suppurativa, and inflammatory bowel disease.
- Rheumatoid arthritis
- Multiple sclerosis
- Atopic dermatitis
- Inflammatory bowel disease
His clinical work also extends to psoriasis and related autoimmune conditions, supporting therapeutic development in chronic immune dysregulation.
Metabolic and Cardiovascular Risk Conditions
His clinical research landscape includes obesity, overweight, hypercholesterolemia, and atherosclerosis, with attention to metabolic disease and associated cardiometabolic risk.
- Obesity
- Hypercholesterolemia
- Atherosclerosis
- Metabolic dysfunction
He is also involved in research relevant to non-alcoholic steatohepatitis, linking metabolic disorders with liver-related therapeutic development.
Healthy Volunteer and Translational Clinical Pharmacology
A substantial part of his portfolio is centered on healthy volunteer studies and clinical pharmacology, including investigations of safety, tolerability, pharmacokinetics, bioavailability, and drug interaction profiles.
- Healthy volunteers
- Pharmacokinetics
- Bioavailability
- Drug interactions
This work spans vaccines, antiviral therapies, and inhaled and oral investigational treatments, supporting early clinical evaluation across multiple therapeutic domains.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.